HomeMy WebLinkAboutResolution - 2024-R0192 - MOU CON30606111, TTUHSC Managed Care, 340B Drug Pricing Program - 04/09/2024Resolution No. 2024-R0192
Item No. 6.34
Apri19, 2024
RESOLUTION
BE IT RESOLV�D BY THE CITY COUNCIL OF TIIE CITY O� LUBBOCK:
THAT the Mayor of the City of Lubbock is hereby authorized and directed to execute for
and on behalf of the City of Lubbock, the Memorandum of Understanding (MOU),
CON3606111, regarding eligibility and participation in the Health Resources and Services
Administration's 340B Drug Pricing Program, by and between the City of Lubbock and "Texas
Tech University Health Sciences Center (TTUHSC), on behalf of TTUHSC Managed Care, and
all related documents. Said MOU is attached hercto and incorporated in this resolution as if
fully set forth herein and shall be included in the minutes of the City Council.
Passed by the City Council on _ �����32p�r#
TRAY Y , YOR
AT'�FST:
Courtney Paz, City Secretary
Al'pROVED AS TO CON'1 LNT:
�!'� ----
Bill How on, Deputy Ci ager
APPROVLD AS TO PORM:
Rachael I'oster, ssistant City Attorney
RES.MOU TTUHSC 340B Drug Pricing Program
3.27.24
Resolution No. 2024-R0192
City of Lubbock
CON3606111
MEMORANDUM OF UNDERSTANDING
This Memorandum of Understanding, (the "MOU"), is entered inta by and between the City of Lubbock, on
behalf of its Health Deparhnent (primary grantee of Section 318 funds of the Public Health Service Act,
hereafter, referred to as PRIMARY GRANTEE) and Texas Tech University Health Sciences Center, a public
institution of higher education in the State of Texas, on behalf of T"TUHSC Managed Care (hereafter, referred
to as the SUBRECIPIEN'1�, (collectively, the "Parties") in an effort to outline the relationship and set out the
roles and responsibilities between the Parties regarding eligibility and participation in the Health Resources
and Services Administration's (HRSA) 340B Drug Pricing Program (the "Program") and to ensure the
coordination and implementation of strategies to support the scope of [PCHD NOFO (19-1901), Ending the
HIV Epidemic (EHE) NOFO (20-2010), or other qualifying Section 318 grant].
RECITALS
WHEREAS, the PRIMARY GRANTEE receives a direct grant from the CDC that uses funds from Section
318 of the Public Health Service Act to be provisioned in compliance with federal and state program
regulations; and
WHEREAS, the SUBRECIPIENT provides services consistent with the purpose of the Section 318 grant,
including but not limited to:
• procuring infectious disease medications through appropriate sources;
• requiring all covered patients to be seen by providers managed by the Subrecipient;
• providing patients appropriate education;
• providing all patients residing within Subrecipient's domain of care appropriate infectious disease
screening; and
WHEREAS, the SUBRECIPIENT receives from the PRIMARY GRANTEE:
• In-kind, non-cash contributions paid for by Section 3l 8 funds in the form of goods and services directly
benefiting and specifically identifiable to the project or program;
• Specimen processing and testing for syphilis;
� Educational brochures;
• Training to correctional facility staff on HIV and STI screening, treatment and care;
• Partner services and linkage to care for individuals diagnosed with viral hepatitis, HN and STIs
(recently released individuals or notifying partners of incarcerated individuals);
• 340B medication(s) paid for by Section 318 funds and distributed through a HRSA-approved
Combined Purchasing and Distribution Model.
NOW THEREFORE in consideration of the mutual promises set forth herein and for other valuable
consideration, the sufficiency of which is hereby acknowledged, the Parties agree as follows:
I. Joint Resnonsibilities
A. Ensure policies and procedures align with Program guidelines and expectations of compliance;
B. Ensure all policies and procedures are implemented and adhered to; and
For 340B Combined Purchasing and Distribution medications only:
I IIIIII IIII� II II II�III III IIIIII IIIIIII I) III'll IIII IIII ( IIIII� IIIIII II II IIIIII III IIIIII IIIIIII II IIIII) IIII IIII
["'CON3806111 21 244241842304770599079278992387720895558782155025 1'7"'] rowareabyasc
City of Lubbock
CON3606111
C. Monitor and track medications from the Combined Purchasing and Distribution Program.
II. PRIMARY GRANTEE Resoonsibilittes
A. Attest to HRSA the eligibiliry of the SUBRECIPIENT to participate in the Program;
B. Provide to the SUBRECIPIENT the federal grant number of the award or the Notice of Funding
Opportunity (NOFO) number under which it is funded for registration in the Office of Pharmacy Affairs
Information System (OPAIS) database;
C. Review, approve, and monitor SUBRECIPIENT's registration in OPAIS;
D. May review and approve the eligibility for each SUBRECIPIENT site to participate in the Program
outlined in Attachment "A";
E. Provide education concerning Program compliance to SUBRECIPIENT through initial and ongoing
technical assistance, including information on how to access the Apexus PVP Program, a HRSA
contractor for further education;
For 340B Combined Purchasing and Distribution medications only:
F. Create, review, and update policies and procedures to ensure compliance with the Combined
Purchasing and Distribution Program;
G. Ensure all 340B medications provided to SUBRECIPIENT are through pre-authorized entities; and
H. Monitor and support the SUBRECIPIENT on all compliance elements of the Program addressed in the
policies and procedures outlined by the Combined Purchasing and Distribution Program.
III. SUBRECIPIENT Resoonsibilities
A. Determine eligibility of participation in the Program for each site listed in Attachment "A";
B. Register as a Covered Entity in OPAIS database, maintaining registration and annual recertification for
all registered sites and associated pharmacies (if applicable) using the Section 318 grant number or
NOFO number NH25PS005182 under which it receives funding or in-kind contributions from. The
OPAIS database can be accessed at: https://340boQais.hrsa. ov/;
C. On a continual basis, ensure all 3408 OPAIS information is accurate and up to date;
D. Ensure program integriry by maintaining accurate records and documenting compliance with all
Program requirements. To the extent authorized by the Constitution and the Iaws of the State of Texas,
the SUBRECIPIENT will be liable and hold the PRIMARY GRANTEE harmless for any findings of
noncompliance by the SUBRECIPIENT;
(IIIII (IIIII II II IIIIII III IIIIII IIII'll II IIIIII IIII IIII ( IIIIII IIIIII II II IIIIII III IIIIII IIIIIII II IIIIII III) III)
["'CON38Q6111'21•244241842304770589079276992387720695558782155025'2'7"') Powm.eeyasc
Ciry of Lubbock
CON3606111
E. Ensure all 340B medications, laboratory, and/or other in-kind services provided under this MOU are
used only for qualifying patients. It is the responsibility of the SUBRECIPIENT to prevent the
diversion of 340B medications to ineligible patients.
F. Report to HRSA and the PRIMARY GRANTEE how the SUBRECIPIENT will bill Medicaid fee-for-
service drugs on the Medicaid Exclusion File, as mandated by 42 USC 256b(a)(5)(A)(i), to ensure
compliance with the Duplicate Discount Prohibition requirements;
G. If applicable, use 340B revenue to promote the purpose of the federal section 318 grant under which it
is 340B eligible;
H. Permit on-site or remoting audit and program monitoring visits by HRSA to ensure compliance with
Program regulations;
I. Notify the PRIMARY GRANTEE of any change in organizational policy relating to the distribution,
storage, and dispensing of 340B medications, change in registration information, non-compliance, or
discontinuation of participation in the program as soon as possible;
For 340B Combined Purchasing and Distribution medications only:
J. Obtain medications from authorized entity designated or approved by the PRIMARY GRANTEE;
K. Distribute medications at no charge to eligible patients;
L. Maintain records of each medication distributed to eligible patients. Records may be requested and
audited by PRIMARY GRANTEE for onsite or remote monitoring at any time to ensure compliance.
Records include, but are not limited to: billing records, medication tracking logs, and relevant patient
records;
M. Will not bill Medicaid or other payors for medications;
N. Ensure medications are not sold or exchanged to any individual or entity; and
O. Report waste or loss of inedications or any discovered non-compliance to the PRIMARY GRANTEE
as soon as possible.
IV. Term of the MOU
This MOU begins upon the first date on which it has been executed by both Parties and ends one year
thereafter. Upon expiration of the original term of this Agreement, this Agreement will continue in full force
and effect on a year-to-year basis, not to exceed four, one-year renewals, unless terminated by either Party.
V. Amendments
Amendments to this MOU sha�l be in writing and signed by the Parties.
PBge 3 Of 7 TTIIHSC
I II'lll IIIIII II II (IIIII III IIIIII IIIIIII I) IIIII� IIII II�I I IIIIII IIIIII II II IIIIII III IIIIII IIIIII) I) III�II III) IIII
[""CON3806111 21 244241842304770598079276992387720695556782155025 3'7 ] Pow�sanyasc
City of Lubbock
CON3606111
VI. Termination of MOU
A. Termination by Mutual Agreement.
Either Party may terminate this MOU, or any part thereof, at any time with written notice sixty days prior to
the date of termination. Upon expiration of the sixty (60) day period, the SUBRECIPIENT shall notify HRSA
and be removed from the 340B Program if otherwise ineligible to participate in the Program.
B. Termination for Cause.
This MOU may be terminated for a material breach upon sixty (60) days written notice of such alleged material
breach. Such notice shall specify in reasonable detail the nature of the breach and the actions required to cure
the breach if such is curable. Termination of this MOU and suspension from the 340B Program shall occur
upon the expiration of said sixty (60) day period if the conditions to resolve the material breach cannot be met.
VII. Additional Terms and Conditions
A. Confidentiality
Confidential Information: All Confidential Information (as defined below) shall be the property of the
disclosing party. Each party agrees the receiving party shall (i) use at least the same degree of care to prevent
unauthorized use and disclosure of disclosing party's Confidential Information as the receiving party uses
concerning its own Confidential Information (but in no case less than a reasonable degree of care); (ii) use the
disclosing party's Confidential Information only in the performance of the receiving party's obligations under
this Agreement or for internal purposes to improve the quality of service performed under this Agreement; and
(iii) except as otherwise expressly provided herein, not disclose or grant access to the disclosing party's
Confidential Information to any third party, without the prior written consent of the disclosing party.
"Confidential Information" means non-public information that the disclosing party designates as being
confidential to the receiving party or which, under the circumstances surrounding disclosure ought to be treated
as confidential by the receiving party, including without limitation, information received from others that the
disclosing party, is obligated to treat as confidential. Confidential Information does not include information
that (i) is or subsequently becomes generally available to the public other than by a breach of a confidentiality
obligation; (ii) is already in the possession of receiving party prior to disclosing party's disclosure to receiving
party; (iii) is independently developed by receiving party without use or reference to the disclosing party's
Confidential Information; (iv) becomes available to receiving party from a source other than the disclosing
party other than by a breach of a confidentiality obligation, or (v) is required to be disclosed by law or
regulation, including Tex. Gov't. Code Ann. Chapter 552 et seq., as amended (the "Texas Public Information
Act").
B. Medical Records
All parties to this Agreement shall comply with all applicable state and federal laws and regulations regarding
confidentiality of patient records, including, but not limited to, the Health Insurance Portability and
Accountability Act of 1996 ("HIPAA") and the Privacy Standards (45 C.F.R. Parts 160 and 164), the Standards
for Electronic Transactions (45 C.F.R. Parts 160 and 162), and the Security Standards (45 C.F.R. Part 162)
2024-03-26 Psge 4 of 7 TTUHSC
I IIIIII IIIIII II II IIIII) III �IIIII IIIIIII I) III�II IIII IIII I IIII'I IIIIII (I II IIIIII III IIIIII I'lllll II IIIIII IIII IIII
["'CON3808111'21'244241842304770598079278982387720895558782155025•4'7"'] newmeanynsc
City of Lubbock
CON3606111
(collectively, the "Standards") promulgated or to be promulgated by the Secretary of Health and Human
Services on and after the applicable effective dates specified in the Standards. Notwithstanding the foregoing,
the parties shall be permitted to enter into such Business Associate Agreements as are permitted or required
by H[P�.
VIII. Entire Aereement
The Parties acknowledge that this MOU, including the incorporated attachments, is the entire agreement of the
Parties and that there are no agreements or understandings, written or oral, between them with the respect to
the subject matter of this MOU, other than as set forth in this MOU. By signing below, the Parties aclmowledge
that they have read the MOU and agree to its terms and that the persons whose signatures appear below have
the requisite authority to execute this MOU on behalf of the named party.
Signature Page follows
2024-03-26 Page 5 of 7 '
I IIIIII (IIII� II II IIIIII III IIIII) IIIIIII �I IIIIII �III III) I I�IIII III�II (I II IIIIII III IIIIII IIIIIII II IIIIII III) (III
['••CON3606111•21•244241842304770599079278982387720895558782155025•5'7"'] �eynsC
City of Lubbock
CON3606111
CITY OF LUBBOCK:
TEXAS TECH UNIVERSITY
HEALTH SCIENCES CENTER:
BY:
T a ay , ayor
�• .� • � .
ATTEST:
BY:
Courtney Paz, City Secretary
APPROVED AS TO CONTENT:
Katherine Wells,
City of Lubbock Health Director
APPROVED AS TO FORM:
achael Foster
Assistant City Attorney
P �
BY; Penny Harkey (Mar , 202414:37 j
NAME: Penny Harkey
TITLE: �ecutive Vice President of Finance and Operations
DATE: 03/26/2024
The following Attachments are attached and incorporated as part of the MOU:
Attachment "A" SUBRECIPIENT's Participating Locations
Attachments follow
2024-03-26 Page 6 of 7 TTUHSC
I IIIIII IIIIII II II IIIIII III IIIIII IIIIII) II II�III IIII IIII I IIIII' IIIIII II II IIIIII III IIIIII I�IIIII II IIIIII IIII (I'I
("'CON3606111 •21 •244241842304770599079276992387720695556782155025'6'7"') aowe,udnynsC
Ciry of Lubbock
CON3606111
Attachment "A"
SUBRECIPIENT's Participating Locations
Site Name Address City ZIP Phone Number
Allred 2101 FM 369 North lowa Park 76367 (940) 855-7477
Baten 1992 Helton Road Pampa 79065 (806) 665-7070
Clements 9601 Spur 591 Amarillo 79107 (806) 381-7080
Dalhart 11950 FM 998 Dalhart 79022 (806) 249-8655
Daniel 938 South FM 1673 Snyder 79549 (325) 573-1114
Formby 998 County Road AA Plainvlew 79072 (806) 296-2448
Fort Stockton 1536 IH-10 East Fort Stockton 79735 (432) 336-7676
Havins 500 FM 45 East Brownwood 76801 (325) 643-5575
Jordan 1992 Helton Road Pampa 79065 (806) 665-7070
L nau h 1098 South Highway Fort Stockton 79735
Y g 2037 (432)395-2938
Middleton 13055 FM 3522 Abilene 79601 (325) 548-9075
Montford 8602 Peach Street Lubbock 79404 (806) 745-1021
Neal*** 9055 S ur 591 Amarillo 79107 (806)383-1175
Roach 15845 FM 164 Childress 79201 (940) 937-6364
Robertson 12071 FM 3522 Abilene 79601 (325) 548-9035
Rudd**' 2004 Lamesa Highway Brownfield 79316 (806)637-6254
Sanchez 3901 State Jail Road EI Paso 79938 (915) 856-0046
Sayle 4176 FM 1800 Breckenridge 76424 (254) 559-1581
Smith 1313 CR 19 Lamesa 79331 (806) 872-6741
Mechler 4000 Highway 86 West Tulia 79088 (806) 995-4109
Wallace 1675 South FM 3525 Colorado Ciry 79512 (325) 728-2162
Wheeler 986 County Road AA Plainview 79072 (806) 296-2448
***Neal and Rudd units are currently idle
2024-03-26 Page 7 of 7
I IIIIII IIIIII II II IIIIII III IIIIII IIIIIII II IIIIII illl IIII I IIIIiI IIIIII II II IIIIII III IIIIII IIIIIII II IIIIII IIII IIII
["•CON36Q8111•21•244241842304770589079278992387720695556782155025'7'7"'] Powa,ednynsc